Search

everythinglearnresearchcommunity

for

Search:↓

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Targeting the AhR pathway may help treat alopecia areata.

Cardamonin reduces inflammation in gum tissue cells.

Retinol may affect immune responses in people with frequent skin boils.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

Higher levels of DHEA and TNF-α are linked to PCOS symptoms.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Topical IKKα inhibitors may help prevent CCS tumours.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

miR-486 may help prevent hair loss in alopecia areata.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Interleukin-1 increases keratin K6 production in skin cells.

Certain gene variations are linked to alopecia areata.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Cholecystokinin may help reduce skin inflammation in psoriasis.

TNF alpha in skin cells causes weight loss, hair and fat issues, and skin inflammation in mice.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Lack of functional CYLD in mice leads to early aging and cancer.